Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2018 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
TELA BIO INC | 8 | Q3 2023 | 7.6% |
REZOLUTE INC | 8 | Q3 2023 | 1.3% |
OPTINOSE INC | 7 | Q3 2023 | 7.9% |
IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-05-16 |
13F-HR | 2024-05-14 |
SC 13G | 2024-03-28 |
13F-HR | 2024-02-14 |
4 | 2024-02-09 |
SC 13D/A | 2024-02-09 |
SC 13G/A | 2024-01-29 |
13F-HR | 2023-11-13 |
4 | 2023-10-04 |
4 | 2023-08-17 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.